Softsu technology joins Taimei medical technology to jointly build medical information solutions

In June 2019, Taimei medical technology and softsu technology jointly announced that Taimei medical technology and softsu technology have signed a final agreement, softsu technology will be incorporated into Taimei medical technology, retain the "softsu" brand and continue to operate as softsu technology legal entity, Mr Li Shenjia will continue to be the general manager of softsu Technology and join the senior leadership team of Taimei medical technology group Taimei medical technology is a leading provider of technology solutions in the field of life science in the industry, ranking the leading position in the field of pharmaceutical research and development, pharmacovigilance, medical affairs, etc Taimei is the world's first trialos ® pharmaceutical R & D collaboration platform, linking hospitals, pharmaceutical enterprises, service providers, regulators, patients and other industry participants, supporting more than 1 / 3 of China's registered clinical research and adverse reactions collection Softsu technology, focusing on the marketing digitalization in the field of life and health, is the most leading pharmaceutical marketing management cloud solution provider in the industry, and its sales of Shenke series products ranks first in the market share of Chinese pharmaceutical marketing CRM Together with softsu, Taimei will provide pharmaceutical industry customers with complete technical and service solutions from pharmaceutical R & D, professional operation to marketing, so as to maximize the operational efficiency of pharmaceutical enterprises, optimize the cost structure and gain an advantageous position in the market competition Mr Zhao Lu, chairman and CEO of Taimei medical technology, said: joining hands with softsu is an important measure for Taimei to realize its mission of "laying out an information superhighway to support the efficient operation of the pharmaceutical industry" Although Taimei and softsu are in different subdivisions, they have the same gene of technology belief, the same simple corporate culture and the same expectation for the future of the industry, which are the basis for the two companies to come together Through the integration and sharing of professional knowledge, technical ability and industry resources, the two sides will promote the informatization process of the pharmaceutical industry, so as to accelerate the pace of new drug research and development and marketing, and ultimately achieve the goal of improving the access of patients to medication Mr Li Shenjia, CEO of softsoft technology, said that softsoft has been committed to providing high-quality solutions for information management and digital marketing in the field of life and health in China for many years This integration with Taimei will greatly promote the integration of industry resources and greatly strengthen the professional output in the subdivision field We look forward to two companies with similar entrepreneurial genes and similar corporate vision, to contribute to the realization of the information-based closed-loop in the field of life and health in China Jeni turtle